Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Tareq Kass-Hout, MD
Jacobs Neurological Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Millard Fillmore Gates Circle Hospital
Buffalo, New York, United States
Adnan H Siddiqui, MD,PhDDavid Janicke, MDElad Levy, MDKenneth V Snyder, MD, PhDL N Hopkins, MDMarilou Ching, MDRobert N Sawyer, MDTareq Kass-Hout, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 31 Dec 2013
- Completion
- 28 Feb 2014
- Last update posted
- 30 Mar 2012
- Registered enrollment
- 90
- Registry id
- NCT01455935
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.